S
Stella M. Davies
Researcher at Cincinnati Children's Hospital Medical Center
Publications - 528
Citations - 25579
Stella M. Davies is an academic researcher from Cincinnati Children's Hospital Medical Center. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 68, co-authored 455 publications receiving 22806 citations. Previous affiliations of Stella M. Davies include University of Cincinnati Academic Health Center & Newcastle University.
Papers
More filters
Journal ArticleDOI
The Barthel ADL Index: a reliability study*
TL;DR: Analysis of total (summed) scores revealed a close correlation between all four methods: a difference of 4/20 points was likely to reflect a genuine difference, and in individual items, most disagreement was minor and involved the definition of middle grades.
Journal ArticleDOI
Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.
John E. Wagner,Juliet N. Barker,Todd E. DeFor,K. Scott Baker,Bruce R. Blazar,Cindy R. Eide,Anne I. Goldman,John H. Kersey,William Krivit,Margaret L. MacMillan,Paul J. Orchard,Charles Peters,Daniel J. Weisdorf,Norma K.C. Ramsay,Stella M. Davies +14 more
TL;DR: There is a high probability of survival in recipients of UCB grafts that are disparate in no more than 2 human leukocyte antigens when the grafts contain at least 1.7 x 10(5) CD34(+) cells per kilogram of recipient's body weight, and graft selection should be based principally on CD34 cell dose when multiple UCB units exist with an HLA disparity of 2 or less.
Journal ArticleDOI
Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease
John E. Wagner,Joseph Rosenthal,Joseph Rosenthal,Robert Sweetman,Robert Sweetman,Xiao-Ou Shu,Xiao-Ou Shu,Stella M. Davies,Stella M. Davies,Norma K.C. Ramsay,Norma K.C. Ramsay,Philip B. McGlave,Philip B. McGlave,Leonard S. Sender,Leonard S. Sender,Mitchell S. Cairo,Mitchell S. Cairo +16 more
TL;DR: Cryopreserved umbilical cord blood from HLA-matched and mismatched unrelated donors is a sufficient source of transplantable hematopoietic stem cells with high probability of donor derived engraftment and low risk of refractory severe acute graft-versus-host disease.
Journal ArticleDOI
Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
Kirk R. Schultz,W. Paul Bowman,Alexander Aledo,William B. Slayton,Harland N. Sather,Meenakshi Devidas,Chenguang Wang,Stella M. Davies,Paul S. Gaynon,Michael E. Trigg,Robert Rutledge,Laura Burden,Dean Jorstad,Andrew J. Carroll,Nyla A. Heerema,Naomi J. Winick,Michael J. Borowitz,Stephen P. Hunger,William L. Carroll,Bruce M. Camitta +19 more
TL;DR: The higher imatinib dosing in cohort 5 appears to improve survival by having an impact on the outcome of children with a higher burden of minimal residual disease after induction, with no appreciable increase in toxicity.
Journal ArticleDOI
Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age
Craig Kollman,Craig W. S. Howe,Claudio Anasetti,Joseph H. Antin,Stella M. Davies,Alexandra H. Filipovich,J Hegland,Naynesh Kamani,Nancy A. Kernan,Roberta King,Voravit Ratanatharathorn,Daniel J. Weisdorf,Dennis L. Confer +12 more
TL;DR: Age should be considered when selecting among comparably HLA-matched volunteer donors and the use of younger donors may lower the incidence of GVHD and improve survival after bone marrow transplantation.